Orozco QM, Domínguez MO, Cano CS

Language: Spanish
References: 17
Page: 131-138
PDF size: 223.58 Kb.

ABSTRACT

At the present time, it is possible the early detection of diseases as cancer, which for a long time has been a public health problem worldwide. It is estimated that between 5 to 10% of all tumors have an hereditary pattern. The advice for hereditary cancer cases is changing the natural history of some of them through the genetic counseling and molecular study of certain syndromes that predispose to this disease and, thus, impacting positively on their morbidity and mortality. The ethical approach is paramount in the care of hereditary cancer, as it focuses on prevention, with the application of individual genetic clear, timely and compelling counseling by the medical geneticist or a committee on bioethics.

REFERENCES

1. INEGI, 2004.

2. Vogelstein B, Kinzler KW. The genetic basis of human cancer. New York: McGraw-Hill Professional, 2002;p:821.

3. Eeles RA, Easton DF, Ponder BAJ, Eng Ch, et al. Genetic Predisposition to Cancer. 2nd ed. Hodder Arnold, 2004;pp:466.

4. Alonso Sánchez Angel, et al. Cáncer hereditario. 1ª ed. Sociedad Española de Oncología Médica (SEOM) e Instituto Roche, 2006.

5. Frank B, Hemminki K, Wirtenberger M, Lorenzo J, et al. The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk. Carcinogenesis 2005;26(3):643-7.

6. Xie D, et al. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J Natl Cancer Inst 2000;92(5):412-7.

7. Rutter JL, et al. The HER2 1655V polymorphism and breast cancer risk in Ashkenazim. Source Epidemiology 2003;14(6):694-700.

8. Nelson SE, Gould MN, Hampton JM, Trentham-Dietz A, et al. A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer. Breast Cancer Research 2005;7:R357-64.

9. Papewalis J, Nikitin AY, Rajewsky MF. G to A polymorphism at amino acid codon 655 of the human erbB-2/HER2 gene. Nucleic Acids Res 1991;19(19):5452.

10. Petrucelli N, et al. BRCA1 and BRCA2 hereditary breast/ovarian cancer gene reviews. Founded by the NHI. Developed at the University of Washington, Seattle, 2004.

11. Salazar-Martínez E, et al. Nutritional determinants of epithelial ovarian cancer risk: A case-control study in Mexico. Oncology 2002;pp:151-7.

12. Kosopoulos J, et al. Towards a dietary prevention of hereditary breast cancer. Cancer Causes Control 2005;16:151-7.

13. Kowalska E, et al. Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation. Cancer Epidemilogy, Biomarkers Prev 2005;14(5):1302-6.

14. Couceiro A. El informe Belmont. En: Bioética para clínicos. Madrid: Triacastela, 1999;pp:313-24.

15. Badía G, Jiménez VJ, Sánchez M. Historia clínica y sistemas de información. En: Atención primaria. Vol. I. 5ª ed. Madrid: Elsevier. 2003;pp:420-3.

16. Camps V. Una Vida de Calidad. Barcelona: Ares y Mares, 2001;p:103.

17. Jonas H. El principio de responsabilidad. Trad. Javier María, Fernández Retenaga. Barcelona: Herder, 1995;p:36.